phosphoserine has been researched along with nadp in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Asara, JM; Blenis, J; Dephoure, N; Gomes, AP; Low, V; McReynolds, MR; Piskounova, E; Rabinowitz, JD; Schaffer, BE; Schild, T; Shea, C | 1 |
1 other study(ies) available for phosphoserine and nadp
Article | Year |
---|---|
NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma.
Topics: Adenocarcinoma; Animals; Biosynthetic Pathways; Carcinogenesis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Female; HEK293 Cells; Humans; Male; Mice, Inbred C57BL; Mice, Nude; NADP; Pancreatic Neoplasms; Phosphorylation; Phosphoserine; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase C; Proto-Oncogene Proteins p21(ras); Signal Transduction | 2021 |